PLAN Conference Development Cardiovascular - Weinstein 2020
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
SPONSORSHIP PLAN Cardiovascular Development Conference May 14-16
2 SPONSORSHIP PLAN - WEINSTEIN 2020
Invitation to the Weinstein Cardiovascular Development
Conference and Regeneration Conference
We welcome you to participate in the 27th Weinstein meeting to be held 14-16 May 2020 at Bonaventure Hotel
in Montreal.
Established in 1994, the Weinstein Cardiovascular Development Conference has helped guide the direction of
cardiac developmental biology research and has driven its success in providing medical impact to newborns
presenting with CHDs. Typical Weinstein Conferences have more than 300 participants, and the meeting is
unique in several ways. First, it is one of the only scientific meetings dedicated to the development of early
career scientists. Second, the meeting is organized and funded solely by academic researchers. Third, there is
great emphasis to present state-of-the-art technologies and unpublished scientific findings.
The Weinstein Cardiovascular Development Conference format includes both platform presentations and pos-
ters sessions that cover a wide spectrum of science which are relevant to understanding heart development
and the origins of CHDs. The meeting schedule includes discussion times, dedicated poster sessions, meals,
and social time, all designed to promote scientific interactions and collaboration
Previous location
The previous conference took place in Indianapolis on May 9-11, 2019 where more than 300 participants
attended the event.
• Medical University of South Carolina Charleston, 1994 •U niversity of California, San Francisco San Francisco,
• University of Rochester Rochester, 1995 2009
• University of Pennsylvania Philadelphia, 1996 • University of Amsterdam Amsterdam, Netherlands, 2010
• University of Cincinnati Cincinnati, 1997 • University of Cincinnati Cincinnati, 2011
• Vanderbilt University Nashville, 1998 • University of Chicago Chicago, 2012
• University of Arizona Tucson, 1999 • University of Arizona Tucson, 2013
• Washington University St. Louis, 2000 •F undación Centro Nacional de Investigaciones Car-
•U niversity of Texas, Southwestern Medical School diovasculares Madrid, Spain, 2014
Dallas, 2001 • Boston Children’s Hospital Boston, 2015
• University of Utah Salt Lake City, 2002 •U niversity of North Carolina at Chapel Hill, North Caro-
• Harvard University Cambridge, 2003 lina State University, and Duke University Durham, 2016
• Leiden University Leiden, Netherlands, 2004 • Nationwide Children’s Hospital Columbus, 2017
• University of Arizona Tucson, 2005 •N ational Cerebral and Cardiovascular Center and Keio
• University of South Florida Tampa/St. Petersburg, 2006 University School of Medicine Nara, Japan 2018
• Indiana University School of Medicine Indianapolis, 2007 • Indiana University School of Medicine Indianapolis 2019
• Texas A&M University of Houston Houston, 2008
SPONSORSHIP PLAN - WEINSTEIN 2020 3
Venue
Located right in the heart of the city, the hotel Bonaventure is just steps away from historic sites, world-class
shopping and dining, the Old Port and the Entertainment District. This means you can enjoy the best of what
Montreal has to offer without having to worry about ground transportation logistics or travel time.
Montreal is Canada’s number one city for research centres and research investment in the life sciences. The city
supports 56,000 industry jobs in 650 organizations, and 10,000 students graduate yearly from health-related
programs. Our expertise encompasses biotechnology, pharmaceuticals, neuroscience, cardiology, oncology
and more.
We’re connected to the world. Our newly revamped Montréal-Trudeau airport (YUL) offers direct flights to
over 150 global destinations, plus we’re less than a 3-hour plane ride to major American cities like New York,
Washington Chicago and Atlanta.
Mission
The Weinstein meeting is the premier opportunity for researchers in the field of cardiovascular development to
meet and share data and ideas. The scientific community that studies cardiac development and CHDs is small,
and this meeting provides a unique opportunity to keep it engaged.
Values
Collaboration : one of the most important aspects of the Weinstein Meeting has been the willingness of the
participants to share new and unpublished information. This has provided opportunities for the participants to
devise new experiments and develop new hypotheses in a collaborative manner. It is expected that all parti-
cipants will participate in a collegial and ethical manner with respect to information obtained at the Weinstein
Meeting. Permission should be obtained before disclosure of another investigator’s unpublished data.
Quality : our research is guided by innovation, best practice, rigour and accuracy. Our understanding of how the
cardiovascular system develops has grown in direct relationship to expansion of the Weinstein Meeting, and
thus its key objectives are to continue to promote a collegiate environment for dissemination and discussion of
innovative scientific findings, and encourage interactions and collaborations.
Care : the Weinstein Conference has become the most important international annual meeting focused on heart
development and congenital heart disease (CHD), which is encountered once in every 100 live human births.
For more than two decades, it has made lasting impacts on understanding the mechanisms that cause CHDs
and to develop strategies that hopefully will reduce mortality.
4 SPONSORSHIP PLAN - WEINSTEIN 2020
SPONSORSHIP PLAN - WEINSTEIN 2020 5
CONDENSED CONFERENCE SCHEDULE
Scientific sessions will be held in Salle de Montréal rooms. Poster sessions will be held in St-Laurent rooms.
THURSDAY MAY 14TH, 2020 AM 14:00 - 15:00
Breakout session
Satellite symposia : 15:00 - 16:30
1. Congenital heart disease specimens Break
2. Bioinformatics 15:30 - 16:50
3. Human genetics Platform session V
16:50 - 17:00
THURSDAY MAY 14TH, 2020 PM Break
13:15 - 13:30 17:00 - 18:00
Welcome and opening remarks Keynote lecture II : Margaret Buckingham
13:30 - 14:50 18:00 - 19:00
Platform session I : Human Genetics Buffet
14:50 - 15:10 18:30 - 22:00
Break Poster session II
15:10 - 16:30
Platform session II
SATURDAY MAY 16TH, 2020
16:30 - 17:00
Break 9:00 - 10:20
Platform session VI
17:00 - 18:00
Keynote lecture I : Jay Shendure 10:20 - 10:50
Break
18:00 - 19:00
Buffet 10:50 - 12:10
Platform session VII
18:30 - 22:00
Poster session I 12:10 - 14:00
Lunch
13:00 - 14:30
FRIDAY MAY 15TH, 2020 NIH presentations
9:00 - 10:20 14:30 - 15:50
Platform session III Platform session IX
10:20 - 10:50 15:50 - 16:10
Break Break
10:50 - 12:10 16:10 - 17:30
Platform session IV Platform session X
12:10 - 14:00 17:30 - 17:45
Lunch Weinstein 2021, Closing Remarks
13:00 - 14:00 18:30 - 23:00
Business meeting Gala diner
6 SPONSORSHIP PLAN - WEINSTEIN 2020
KEYNOTE SPEAKERS
Jay Shendure is an Investigator of the Howard Hughes Medical Institute,
Professor of Genome Sciences at the University of Washington, Director of
the Allen Discovery Center for Cell Lineage Tracing, and Scientific Direc-
tor of the Brotman Baty Institute for Precision Medicine. His 2005 doctoral
thesis with George Church included one of the first successful reductions to
practice of next generation DNA sequencing. Dr. Shendure’s research group
in Seattle pioneered exome sequencing and its earliest applications to gene
discovery for Mendelian disorders and autism ; cell-free DNA diagnostics for
cancer and reproductive medicine ; massively parallel reporter assays, satu-
ration genome editing ; whole organism lineage tracing, and massively parallel
molecular profiling of single cells. Dr. Shendure is the recipient of the 2012
Curt Stern Award from the American Society of Human Genetics, the 2013
FEDERAprijs, a 2013 NIH Director’s Pioneer Award, the 2014 Hudson Alpha
Life Sciences Prize, the 2018 Richard and Carol Hertzberg Prize for Technology
JAY SHENDURE Innovation, and the 2019 Richard Lounsbery Award from the National Acade-
my of Sciences. He serves or has served as an advisor to the NIH Director, the
US Precision Medicine Initiative, the National Human Genome Research Insti-
tute, the Chan-Zuckerberg Initiative and the Allen Institutes for Cell Science and
Immunology. He received his MD and PhD degrees from Harvard Medical
School in 2007.
Margaret Buckingham is a developmental biologist. She is interested in how
naïve multipotent cells acquire tissue specificity during embryogenesis. She
has studied both the formation of skeletal muscle and of the heart, using
the tools of mouse molecular genetics to characterise cell behaviour and to
identify the genes that govern cell fate choices. She showed the central role
of Pax3 in the gene regulatory network that leads to the onset of myogene-
sis and demonstrated the presence of a population of Pax3/Pax7 positive
progenitors that are essential for foetal muscle development. Her research
extends to the stem cells of adult muscle and their maintenance as reserve
cells for muscle regeneration. Her main contribution to the field of cardioge-
nesis is the identification of the second heart field as a major source of
cardiac progenitor cells that form specific regions of the heart. Retrospective
clonal analysis established a lineage tree for the myocardium, where the second
lineage defines this contribution and reveals the clonal relationships between
MARGARET different sublineages which contribute to both the poles of the heart and ante-
BUCKINGHAM rior skeletal muscles. In addition to its conceptual importance for cardiogenesis,
this work also has biomedical implications for congenital heart malformations.
Margaret was educated in Scotland and at Oxford University where she
obtained B.A., M.A. and D.Phil. degrees in Biochemistry. As a postdoc, she
then joined François Gros at the Pasteur Institute in Paris where she subse-
quently pursued her scientific career. She is currently honorary professor at the
Pasteur Institute and emeritus research director in the CNRS. In 2013, she was
awarded the gold medal of the CNRS. She is a member of the French Academy
of Sciences, a foreign/honorary member of the Royal Society of London/Edin-
burgh and a foreign associate of the National Academy of Sciences of the USA.
SPONSORSHIP PLAN - WEINSTEIN 2020 7Benefits for exhibitors
• Sponsorship provides an excellent opportunity to promote your organisation and support your brand,
maintaining a high profile among specialists, before, during and after this event.
• Delegates are keen to improve their knowledge and skills. Aligning your company with this powerful educational
experience shows your commitment to assisting their development. This will help to cement brand loyalty.
• Sponsorship also provides you with an opportunity to renew relationships and establish new professional
connections.
• Your company’s representatives will be able to benefit this unique opportunity to meet face to face with more
than 300 academic researcher, students, and scientists from around the world both formal and social settings.
• Sponsors will benefit from an interested, relevant and influential audience in an educational/social environment
away from the competition of everyday distractions. This may lead to new or increased sales.
Weinstein Meeting Numbers
Where the 300 participants come from :
Delegate profile
Basic scientists, clinicians and physician-scientists interact and discuss many diverse aspects related to
cardiovascular embryology and its impact on congenital heart disease and adult cardiac dysfunction.
8 SPONSORSHIP PLAN - WEINSTEIN 2020SPONSORSHIP PLAN - WEINSTEIN 2020 9
Partnership programs
We have established official presenter, ambassador, and builder sponsorship
opportunities for this event, but we would be grateful for any donation that you
are able to provide. The scientific community that studies cardiac development
and CHDs is small, and this meeting provides a unique opportunity to keep it
engaged. The sponsorship levels are defined below :
GOLD PARTNER $10,000
Your company may be entitled to the following benefits :
• Sponsor logo displayed in stationary position on conference home page and hyperlinked
• Sponsor identified in pre- and post-conference communications (email, press, Facebook and Twitter)
• Sponsor identified in conference program distributed to all attendees
• Exhibit space with one (1) table, two (2) chairs, wireless internet and one (1) outlet
• Access to meeting rooms to conduct business at conference (by request and based on availability)
WORKSHOP SATELLITE PARTNER $5,000 - $10,000
Your company may be entitled to the following benefits :
• Sponsor logo displayed in stationary position on conference home page and hyperlinked
• Sponsor identified in pre- and post-conference communications (email, press, Facebook and Twitter)
• Sponsor identified in conference program distributed to all attendees
• Exhibit space with one (1) table, two (2) chairs, wireless internet and one (1) outlet
• Access to meeting rooms to conduct business at conference (by request and based on availability)
• Possibility for your company to give a short presentation
10 SPONSORSHIP PLAN - WEINSTEIN 2020SILVER PARTNER $1,000 - $5,000
Your company will be entitled to the following benefits :
• Sponsor logo displayed in stationary position on conference home page and hyperlinked
• Sponsor identified in pre- and post-conference communications (email, press, Facebook and Twitter)
• Exhibit space with one (1) table, two (2) chairs, wireless internet and one (1) outlet
• Sponsor identified in conference program distributed to all attendees
BRONZE PARTNER $500 - $1,000
Your company will be entitled to the following benefits :
• Sponsor logo displayed in conference home page and hyperlinked
• Sponsor identified in conference program distributed to all attendees
• Distribution of promotional products from your company (advertising, marketing items...)
SPONSORSHIP PLAN - WEINSTEIN 2020 11For more information :
Catherine Pichette
514 291-1725
catherinepichette@kubidez.comYou can also read
